Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,942 | -64,152 | -49,917 | -25,279 | -163,415 |
| Depreciation Amortization | 25,290 | 18,818 | 12,339 | 6,078 | 11,946 |
| Accounts receivable | -11,426 | -562 | 7,538 | 12,969 | -43,974 |
| Other Working Capital | 22,591 | 24,273 | 25,505 | 23,942 | -19,221 |
| Other Operating Activity | 61,812 | 37,016 | 15,944 | -2,498 | 143,720 |
| Operating Cash Flow | $10,325 | $15,393 | $11,409 | $15,212 | $-70,944 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -69,132 | -69,793 | -61,938 | 0 | 125,671 |
| PPE Investments | -993 | -973 | -792 | -13 | -109 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -212,762 |
| Purchase Sale Intangibles | -20,000 | -20,000 | -10,000 | N/A | -20,000 |
| Other Investing Activity | -20,000 | -20,000 | -10,000 | 0 | -20,000 |
| Investing Cash Flow | $-90,125 | $-90,766 | $-72,730 | $-13 | $-107,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 305,304 |
| Common Stock Issued | 17,699 | 12,359 | 8,496 | 1,205 | 227,154 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -195,858 |
| Financing Cash Flow | $17,699 | $12,359 | $8,496 | $1,205 | $336,600 |
| Exchange Rate Effect | -1,297 | 82 | -6 | 113 | -133 |
| Beginning Cash Position | 286,326 | 286,326 | 286,326 | 286,326 | 128,003 |
| End Cash Position | 222,928 | 223,394 | 233,495 | 302,843 | 286,326 |
| Net Cash Flow | $-63,398 | $-62,932 | $-52,831 | $16,517 | $158,323 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,325 | 15,393 | 11,409 | 15,212 | -70,944 |
| Capital Expenditure | -993 | -973 | -792 | -13 | -109 |
| Free Cash Flow | 9,332 | 14,420 | 10,617 | 15,199 | -71,053 |